Pirola A - Search Results

1

Identification of genetic polymorphisms modulating nausea and vomiting in two series of opioid-treated cancer patients.

Colombo F, Pintarelli G, Galvan A, Noci S, Corli O, Skorpen F, Klepstad P, Kaasa S, Pigni A, Brunelli C, Roberto A, Piazza R, Pirola A, Gambacorti-Passerini C, Caraceni AT. Colombo F, et al. Among authors: pirola a. Sci Rep. 2020 Jan 17;10(1):542. doi: 10.1038/s41598-019-57358-y. Sci Rep. 2020. PMID: 31953506 Free PMC article.

2

BCR and BCR-ABL regulation during myeloid differentiation in healthy donors and in chronic phase/blast crisis CML patients.

Marega M, Piazza RG, Pirola A, Redaelli S, Mogavero A, Iacobucci I, Meneghetti I, Parma M, Pogliani EM, Gambacorti-Passerini C. Marega M, et al. Among authors: pirola a. Leukemia. 2010 Aug;24(8):1445-9. doi: 10.1038/leu.2010.101. Epub 2010 Jun 3. Leukemia. 2010. PMID: 20520635

3

FusionAnalyser: a new graphical, event-driven tool for fusion rearrangements discovery.

Piazza R, Pirola A, Spinelli R, Valletta S, Redaelli S, Magistroni V, Gambacorti-Passerini C. Piazza R, et al. Among authors: pirola a. Nucleic Acids Res. 2012 Sep;40(16):e123. doi: 10.1093/nar/gks394. Epub 2012 May 8. Nucleic Acids Res. 2012. PMID: 22570408 Free PMC article.

4

Recurrent SETBP1 mutations in atypical chronic myeloid leukemia.

Piazza R, Valletta S, Winkelmann N, Redaelli S, Spinelli R, Pirola A, Antolini L, Mologni L, Donadoni C, Papaemmanuil E, Schnittger S, Kim DW, Boultwood J, Rossi F, Gaipa G, De Martini GP, di Celle PF, Jang HG, Fantin V, Bignell GR, Magistroni V, Haferlach T, Pogliani EM, Campbell PJ, Chase AJ, Tapper WJ, Cross NC, Gambacorti-Passerini C. Piazza R, et al. Among authors: pirola a. Nat Genet. 2013 Jan;45(1):18-24. doi: 10.1038/ng.2495. Epub 2012 Dec 9. Nat Genet. 2013. PMID: 23222956 Free PMC article.

5

Gene expression signature of non-involved lung tissue associated with survival in lung adenocarcinoma patients.

Galvan A, Frullanti E, Anderlini M, Manenti G, Noci S, Dugo M, Ambrogi F, De Cecco L, Spinelli R, Piazza R, Pirola A, Gambacorti-Passerini C, Incarbone M, Alloisio M, Tosi D, Nosotti M, Santambrogio L, Pastorino U, Dragani TA. Galvan A, et al. Among authors: pirola a. Carcinogenesis. 2013 Dec;34(12):2767-73. doi: 10.1093/carcin/bgt294. Epub 2013 Aug 25. Carcinogenesis. 2013. PMID: 23978379

6

CEQer: a graphical tool for copy number and allelic imbalance detection from whole-exome sequencing data.

Piazza R, Magistroni V, Pirola A, Redaelli S, Spinelli R, Redaelli S, Galbiati M, Valletta S, Giudici G, Cazzaniga G, Gambacorti-Passerini C. Piazza R, et al. Among authors: pirola a. PLoS One. 2013 Oct 4;8(10):e74825. doi: 10.1371/journal.pone.0074825. eCollection 2013. PLoS One. 2013. PMID: 24124457 Free PMC article.

7

Identification of novel point mutations in splicing sites integrating whole-exome and RNA-seq data in myeloproliferative diseases.

Spinelli R, Pirola A, Redaelli S, Sharma N, Raman H, Valletta S, Magistroni V, Piazza R, Gambacorti-Passerini C. Spinelli R, et al. Among authors: pirola a. Mol Genet Genomic Med. 2013 Nov;1(4):246-59. doi: 10.1002/mgg3.23. Epub 2013 Jul 7. Mol Genet Genomic Med. 2013. PMID: 24498620 Free PMC article.

8

Treatment Efficacy and Resistance Mechanisms Using the Second-Generation ALK Inhibitor AP26113 in Human NPM-ALK-Positive Anaplastic Large Cell Lymphoma.

Ceccon M, Mologni L, Giudici G, Piazza R, Pirola A, Fontana D, Gambacorti-Passerini C. Ceccon M, et al. Among authors: pirola a. Mol Cancer Res. 2015 Apr;13(4):775-83. doi: 10.1158/1541-7786.MCR-14-0157. Epub 2014 Nov 24. Mol Cancer Res. 2015. PMID: 25421750

9

NPM/ALK mutants resistant to ASP3026 display variable sensitivity to alternative ALK inhibitors but succumb to the novel compound PF-06463922.

Mologni L, Ceccon M, Pirola A, Chiriano G, Piazza R, Scapozza L, Gambacorti-Passerini C. Mologni L, et al. Among authors: pirola a. Oncotarget. 2015 Mar 20;6(8):5720-34. doi: 10.18632/oncotarget.3122. Oncotarget. 2015. PMID: 25749034 Free PMC article.

10

Age and dPCR can predict relapse in CML patients who discontinued imatinib: the ISAV study.

Mori S, Vagge E, le Coutre P, Abruzzese E, Martino B, Pungolino E, Elena C, Pierri I, Assouline S, D'Emilio A, Gozzini A, Giraldo P, Stagno F, Iurlo A, Luciani M, De Riso G, Redaelli S, Kim DW, Pirola A, Mezzatesta C, Petroccione A, Lodolo D'Oria A, Crivori P, Piazza R, Gambacorti-Passerini C. Mori S, et al. Among authors: pirola a. Am J Hematol. 2015 Oct;90(10):910-4. doi: 10.1002/ajh.24120. Epub 2015 Sep 10. Am J Hematol. 2015. PMID: 26178642 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

53 results

Search Page